Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check3 days agoChange DetectedAdded Tainan, Taiwan as a study site and removed Tainan City, Taiwan from the location list.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNo core study content changed: the title, design, arms, primary and secondary outcomes, eligibility criteria, and locations remain the same; observed differences are limited to minor formatting and layout adjustments of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedUpdate: page now includes a government-operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check47 days agoChange DetectedUpdate includes a new version tag (v3.1.0) and removal of several risk-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2).SummaryDifference0.2%

- Check61 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.